Price Wealth’s Edwards Lifesciences EW Stock Holding History

Price Wealth’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	$18K	Sell	220 -68	-24%	-$5.31K	0.01%	197
2020 Q2	$20K	Buy	288 +63	+28%	+$4.48K	0.01%	122
2020 Q1	$14K	Sell	225 -483	-68%	-$34.8K	0.01%	138
2019 Q4	$55K	Buy	708 +18	+3%	+$1.41K	0.02%	107
2019 Q3	$51K	Hold	690	–	–	0.02%	116
2019 Q2	$42K	Hold	690	–	–	0.01%	135
2019 Q1	$44K	Hold	690	–	–	0.02%	96
2018 Q4	$35K	Sell	690 -216	-24%	-$10.9K	0.01%	101
2018 Q3	$53K	Sell	906 -63	-7%	-$3.08K	0.02%	82
2018 Q2	$47K	Buy	+969	New	+$45.2K	0.02%	113

Other funds holding EW

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Price Wealth's EW Position: Q3 2020 in Review

Price Wealth reduced its Edwards Lifesciences (EW) stake by 24% in Q3 2020, selling an estimated $5.31K and leaving 220 shares worth $18K. The position accounts for 0.01% of the portfolio, ranked #197.

Price Wealth first reported a position in EW in Q2 2018 and has held it in 10 quarters since. The position peaked at $55K in Q4 2019. 1,083 funds tracked by Wall St. Rank hold EW as of Q3 2020.

Price Wealth held 220 shares of Edwards Lifesciences worth $18K as of Q3 2020.
Price Wealth sold 68 Edwards Lifesciences shares in Q3 2020, an estimated $5.31K.
Edwards Lifesciences made up 0.01% of Price Wealth's portfolio in Q3 2020, its #197 holding.
Price Wealth first reported a position in Edwards Lifesciences in Q2 2018 and has held it in 10 quarters since.
Price Wealth's Edwards Lifesciences position peaked at $55K in Q4 2019.
1,083 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2020.

Based on Price Wealth's 13F filing for Q3 2020, filed 22 Oct 2020.